Cancer drug hope raises Genmab's spirits after legal defeat
Biotech firm Genmab and partner Abbvie have delivered promising topline data from their shared drug hope epcoritamab, a bone marrow cancer treatment. An important validation for Genmab, assesses an analyst, as the company recently lost an important legal battle.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
The show must go on, as the saying goes, which is also true for the biotech sector.